| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 131 |
| 1 | VEDOLIZUMAB | 51 |
| 2 | AZATHIOPRINE | 31 |
| 3 | USTEKINUMAB | 28 |
| 4 | INFLIXIMAB | 25 |
| 5 | ADALIMUMAB-AATY | 23 |
| 6 | PANTOPRAZOLE | 22 |
| 7 | PREDNISONE | 20 |
| 8 | ADALIMUMAB-ADAZ | 18 |
| 9 | ADALIMUMAB-FKJP | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBON DIOXIDE | 1 | 0.0087 |
| 1 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 2 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 3 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 4 | COLESTIPOL HYDROCHLORIDE | 4 | 0.0015 |
| 5 | PSYLLIUM HUSK | 2 | 0.0015 |
| 6 | THIOGUANINE | 2 | 0.0009 |
| 7 | VEDOLIZUMAB | 51 | 0.0006 |
| 8 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 9 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 52 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 46 |
| 2 | Interleukin-23 Antagonist [EPC] | 37 |
| 3 | Corticosteroid [EPC] | 35 |
| 4 | Purine Antimetabolite [EPC] | 31 |
| 5 | Interleukin-12 Antagonist [EPC] | 28 |
| 6 | Janus Kinase Inhibitor [EPC] | 16 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 9 | Aminosalicylate [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Integrin Receptor Antagonist [EPC] | 52 | 0.0006 |
| 2 | Interleukin-23 Antagonist [EPC] | 37 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 4 | Purine Antimetabolite [EPC] | 31 | 0.0003 |
| 5 | Interleukin-12 Antagonist [EPC] | 28 | 0.0003 |
| 6 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 7 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 8 | Aminosalicylate [EPC] | 13 | 0.0001 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 7 | 0.0001 |